Polymer-Based Nanostructures for Encapsulation, Conjugation, and Therapeutic Delivery
General Material Designation
[Thesis]
First Statement of Responsibility
Jafari, Amin
Subsequent Statement of Responsibility
Cheng, Chong
.PUBLICATION, DISTRIBUTION, ETC
Name of Publisher, Distributor, etc.
State University of New York at Buffalo
Date of Publication, Distribution, etc.
2019
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
184
DISSERTATION (THESIS) NOTE
Dissertation or thesis details and type of degree
Ph.D.
Body granting the degree
State University of New York at Buffalo
Text preceding or following the note
2019
SUMMARY OR ABSTRACT
Text of Note
Effective delivery of therapeutic agents, such as free drug molecules and genes, to specific biological sites presents a significant challenge for biomedical researchers. Several biological barriers are hindering the delivery of free therapeutic materials directly to the diseased tissue, such as degradation by serum protein absorption, macrophage internalization, sequestration in the reticuloendothelial system, clearance by the kidney, etc. Over the past decades, nanocarriers have emerged as promising biomaterials that may overcome biological barriers, protect the therapeutic cargo, and effectively deliver them to the diseased tissue. Polymer-based nanocarriers have drawn tremendous interest because of their significant potential to improve therapeutic biocompatibility, solubility, bioavailability, controlled release, and also minimizing therapeutic toxicity, and nonspecific interactions. With a thoughtful structural design, they can exhibit provide biomedical-relevant stimuli-responsive behavior via variables such as pH, light, and temperatures. The formulation of novel polymer-based nanocarriers for therapeutic delivery has been the focus of many researchers over the past decades. Aligned with such a research direction, this dissertation research includes two major projects: 1) nanocapsules preparation by layer-by-layer (LBL) self-assembly, and 2) synthesis and development of multiple polycaprolactone (PCL)-based nanocarriers for drug and gene delivery applications.